266 related articles for article (PubMed ID: 18571769)
1. Pediatric morphea (localized scleroderma): review of 136 patients.
Christen-Zaech S; Hakim MD; Afsar FS; Paller AS
J Am Acad Dermatol; 2008 Sep; 59(3):385-96. PubMed ID: 18571769
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory arthritis in pediatric patients with morphea.
Kashem SW; Correll CK; Vehe RK; Hobday PM; Binstadt BA; Maguiness SM
J Am Acad Dermatol; 2018 Jul; 79(1):47-51.e2. PubMed ID: 29535035
[TBL] [Abstract][Full Text] [Related]
3. Remission rates and risk factors for relapse in pediatric morphea: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG).
Bağlan E; Kızıldağ Z; Çağlayan Ş; Çakmak F; Yener GO; Özdel S; Öztürk K; Makay B; Çakan M; Ayaz NA; Sözeri B; Ünsal ŞE; Bülbül M
Clin Rheumatol; 2023 Oct; 42(10):2855-2860. PubMed ID: 37378874
[TBL] [Abstract][Full Text] [Related]
4. Linear morphea: a case series with long-term follow-up of young, methotrexate-treated patients.
Koch SB; Cerci FB; Jorizzo JL; Krowchuk DP
J Dermatolog Treat; 2013 Dec; 24(6):435-8. PubMed ID: 23758214
[TBL] [Abstract][Full Text] [Related]
5. [Localized scleroderma (morphea)].
Bono W; Dupin N
Presse Med; 2006 Dec; 35(12 Pt 2):1923-8. PubMed ID: 17159718
[TBL] [Abstract][Full Text] [Related]
6. Interventions for morphea.
Albuquerque JV; Andriolo BN; Vasconcellos MR; Civile VT; Lyddiatt A; Trevisani VF
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD005027. PubMed ID: 31309547
[TBL] [Abstract][Full Text] [Related]
7. Low effectiveness of methotrexate in the management of localised scleroderma (morphea) based on an ultrasound activity score.
Vera-Kellet C; Meza-Romero R; Moll-Manzur C; Ramírez-Cornejo C; Wortsman X
Eur J Dermatol; 2021 Dec; 31(6):813-821. PubMed ID: 35107072
[TBL] [Abstract][Full Text] [Related]
8. Clinical Profile of Methotrexate-resistant Juvenile Localised Scleroderma.
Hardy J; Boralevi F; Mallet S; Cabrera N; Belot A; Phan A; Barbarot S; Duriez-Lasek A; Chiaverini C; Hubiche T; Mahé E; Bégon E; Bourrat E; Boccara O; Aubert H; Lerosey MG; Droitcourt C; Piram M; Mazereeuw-Hautier J;
Acta Derm Venereol; 2019 May; 99(6):539-543. PubMed ID: 30810215
[TBL] [Abstract][Full Text] [Related]
9. [Localized scleroderma (morphea) in childhood].
Weibel L
Hautarzt; 2012 Feb; 63(2):89-96. PubMed ID: 22290277
[TBL] [Abstract][Full Text] [Related]
10. Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases.
Leitenberger JJ; Cayce RL; Haley RW; Adams-Huet B; Bergstresser PR; Jacobe HT
Arch Dermatol; 2009 May; 145(5):545-50. PubMed ID: 19451498
[TBL] [Abstract][Full Text] [Related]
11. Morphea and Eosinophilic Fasciitis: An Update.
Mertens JS; Seyger MMB; Thurlings RM; Radstake TRDJ; de Jong EMGJ
Am J Clin Dermatol; 2017 Aug; 18(4):491-512. PubMed ID: 28303481
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of methotrexate in the treatment of en coup de sabre (linear morphea subtype).
Rattanakaemakorn P; Jorizzo JL
J Dermatolog Treat; 2018 Mar; 29(2):197-199. PubMed ID: 28604132
[TBL] [Abstract][Full Text] [Related]
13. Progressive linear scleroderma and morphea in a child.
Foeldvari I
J Pediatr; 1998 Aug; 133(2):308. PubMed ID: 9709731
[No Abstract] [Full Text] [Related]
14. Localized scleroderma: a series of 52 patients.
Toledano C; Rabhi S; Kettaneh A; Fabre B; Fardet L; Tiev KP; Cabane J
Eur J Intern Med; 2009 May; 20(3):331-6. PubMed ID: 19393504
[TBL] [Abstract][Full Text] [Related]
15. Frequency of antinuclear antibodies in mestizo Mexican children with morphea.
Guevara-Gutiérrez E; Yinh-Lao J; García-Gutiérrez P; Tlacuilo-Parra A
Clin Rheumatol; 2010 Sep; 29(9):1055-9. PubMed ID: 20549277
[TBL] [Abstract][Full Text] [Related]
16. Morphea and localized scleroderma in children.
Vierra E; Cunningham BB
Semin Cutan Med Surg; 1999 Sep; 18(3):210-25. PubMed ID: 10468041
[TBL] [Abstract][Full Text] [Related]
17. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study.
Zulian F; Athreya BH; Laxer R; Nelson AM; Feitosa de Oliveira SK; Punaro MG; Cuttica R; Higgins GC; Van Suijlekom-Smit LW; Moore TL; Lindsley C; Garcia-Consuegra J; Esteves Hilário MO; Lepore L; Silva CA; Machado C; Garay SM; Uziel Y; Martini G; Foeldvari I; Peserico A; Woo P; Harper J;
Rheumatology (Oxford); 2006 May; 45(5):614-20. PubMed ID: 16368732
[TBL] [Abstract][Full Text] [Related]
18. Juvenile case of multiple morphea profunda resulting in joint contracture that was successfully treated with cyclosporin A: A case report and review of the published works.
Ogawa T; Okiyama N; Takamuki R; Inoue S; Saito A; Nakamura Y; Ishitsuka Y; Watanabe R; Fujisawa Y; Fujimoto M
J Dermatol; 2019 Apr; 46(4):354-357. PubMed ID: 30701571
[TBL] [Abstract][Full Text] [Related]
19. A retrospective study: Impact of consensus treatment plans on systemic therapy of pediatric morphea.
Do N; Ringold S; Sullivan E; Brandling-Bennett H
Pediatr Dermatol; 2020 Mar; 37(2):278-283. PubMed ID: 31967352
[TBL] [Abstract][Full Text] [Related]
20. "Borrelia-associated early-onset morphea": a particular type of scleroderma in childhood and adolescence with high titer antinuclear antibodies? Results of a cohort analysis and presentation of three cases.
Prinz JC; Kutasi Z; Weisenseel P; Pótó L; Battyáni Z; Ruzicka T
J Am Acad Dermatol; 2009 Feb; 60(2):248-55. PubMed ID: 19022534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
